These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2337680)

  • 1. Toxicity of novel anthracycline derivatives towards normal myeloid bone marrow progenitor cells (CFU-GM) is not increased by verapamil.
    Busch FW; Schmittele U; Ehninger G
    Blut; 1990 Apr; 60(4):219-22. PubMed ID: 2337680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of verapamil on etoposide, vincristine, and adriamycin activity in normal human bone marrow granulocyte-macrophage progenitors and in human K562 leukemia cells in vitro.
    Yalowich JC; Zucali JR; Gross M; Ross WE
    Cancer Res; 1985 Oct; 45(10):4921-4. PubMed ID: 3861238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium antagonists on anti-cancer drug toxicity to haematopoietic progenitor cells in normal human bone marrow.
    Nakarai T; Koizumi S
    Leuk Res; 1990; 14(5):401-5. PubMed ID: 2345465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of idarubicin and doxorubicin towards normal and leukemic human bone marrow progenitors in relation to their proliferative state.
    Minderman H; Linssen P; van der Lely N; Wessels J; Boezeman J; de Witte T; Haanen C
    Leukemia; 1994 Mar; 8(3):382-7. PubMed ID: 8127143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
    Smith MA; Merry S; Smith JG; Kaye SB
    Br J Cancer; 1988 Jun; 57(6):576-8. PubMed ID: 3408645
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulating myeloid progenitor cell kinetics during hematologic recovery from chemotherapy and subsequent recombinant human granulocyte-macrophage colony-stimulating factor administration.
    Ventura GJ; Reading CL; Hester JP; Vadhan-Raj S
    Acta Haematol; 1990; 84(4):175-81. PubMed ID: 2125781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.
    Soudon J; Berlion M; Lucas C; Haddad P; Bizzari JP; Calvo F
    Cancer Chemother Pharmacol; 1995; 36(3):195-203. PubMed ID: 7781138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo myelotoxicity of CAI to human and murine hematopoietic progenitor cells.
    Volpe DA; Cole K; Sandeen MA; Kohn EC
    Am J Hematol; 1995 Dec; 50(4):277-82. PubMed ID: 7485102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    Young JW; Szabolcs P; Moore MA
    J Exp Med; 1995 Oct; 182(4):1111-9. PubMed ID: 7561684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of the myelotoxicity of cyclopentenyl cytosine.
    Volpe DA; Du DL; Grieshaber CK; Murphy MJ
    Cancer Chemother Pharmacol; 1994; 34(2):103-8. PubMed ID: 8194161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.
    Erickson-Miller CL; May RD; Tomaszewski J; Osborn B; Murphy MJ; Page JG; Parchment RE
    Cancer Chemother Pharmacol; 1997; 39(5):467-72. PubMed ID: 9054963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro studies of haematopoietic colony-forming capacity of human fetal liver cells at exposure to cytotoxic and immunomodulatory drugs.
    Lindton B; Markling L; Ringdén O; Westgren M
    Fetal Diagn Ther; 2002; 17(2):104-9. PubMed ID: 11844915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacious but insidious: a retrospective analysis of fludarabine-induced myelotoxicity using long-term culture-initiating cells in 100 follicular lymphoma patients.
    Janikova A; Koristek Z; Vinklarkova J; Pavlik T; Sticha M; Navratil M; Kral Z; Vasova I; Mayer J
    Exp Hematol; 2009 Nov; 37(11):1266-73. PubMed ID: 19654036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stem cell factor on myelopoiesis potential in human Dexter-type culture systems.
    Liesveld JL; Broudy VC; Harbol AW; Abboud CN
    Exp Hematol; 1995 Mar; 23(3):202-9. PubMed ID: 7533098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.